Per Norstedt, Regional Manager, AH Diagnostics

Why are you going to Scanlab+Biotech Forum?

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Cellavision utser USA-chef

Blodanalysbolaget expanderar verksamheten i Nordamerika.

Hansa Medical vill ta in pengar

Årsstämman om en månad ska ta ställning till styrelsens förslag om nyemission och en rad andra förändringar.

Livet från den ljusare sidan

Personer med vinterdepression eller vintertrötthet har nytta av ljusterapi. Det visar en ny avhandling som om några dagar läggs fram vid Uppsala universitet.

Hallå där Øystein Lie....

....koordinator på nätverket Mare Life som anordnar en workshop på North Atlantic Seafood Forum i dag - Vad är Mare Life för något?

EU satsar på lokalt riskkapital

Knappt nittio miljoner kronor finns i en ny riskkapitalfond som ska investera i mellansvenska tillväxtföretag. Det blir den största EU-satsningen hittills i regionen.

Cellavision klart för börsen

Cellavision har beviljats anslutning till det nya marknadssegmentet First North Premier och kommer att finnas till handel inom kort.

Läkare ska diskutera välfärdssjukdomar

Sju regionala läkemedelskommittéer arrangerar ett nytt forum där läkare ska kunna fortbilda sig oberoende av läkemedelsindustrin.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

LEO Pharma - International Clinical Trial Manager

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.